Day: December 20, 2021
MICHIGAN CITY, Ind., Dec. 20, 2021 (GLOBE NEWSWIRE) — (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m. CT on Thursday, January 27, 2022 to review its fourth quarter 2021 financial results.
The Company’s fourth quarter 2021 news release will be released after markets close on Wednesday, January 26, 2022. It will be available in the “Investor Relations” section of the Company’s website, www.horizonbank.com.
Participants may access the live conference call on January 27, 2022 at 7:30 a.m. CT (8:30 a.m. ET) by dialing 833-974-2379 from the United States, 866-450-4696 from Canada or 412-317-5772 from international locations and requesting the “Horizon Bancorp Call.” Please dial in approximately 10 minutes prior to the call.
A telephone replay of the call will be available...
Host Hotels & Resorts Acquires The Alida, Savannah and Disposes of W Hollywood
Written by Customer Service on . Posted in Public Companies.
BETHESDA, Md., Dec. 20, 2021 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST), the nation’s largest lodging real estate investment trust (the “Company”), today announced that it has acquired the fee simple interest in The Alida, Savannah, a 173-room boutique hotel, for approximately $103 million in cash.
This newly constructed hotel opened in October 2018 and benefits from soft branding in Marriott’s Tribute Portfolio. Rooms average 371 square feet with high ceilings, hardwood floors, built-in window seats and marble bathrooms. The hotel offers 11,570 square feet of meeting space (5,170 indoor), four F&B outlets including a rooftop bar with panoramic views, an outdoor pool, and street-front retail space.
Stabilization for The Alida is expected in the 2024-2025 timeframe at approximately 11-12x...
Simmons First National Corporation Announces Fourth Quarter 2021 Earnings Release Date and Conference Call
Written by Customer Service on . Posted in Public Companies.
PINE BLUFF, Ark., Dec. 20, 2021 (GLOBE NEWSWIRE) — Simmons First National Corp. (NASDAQ: SFNC) today announced it expects to release fourth quarter 2021 earnings prior to the market opening on Thursday, January 27, 2022. Management will conduct a live conference call to review this information beginning at 9:00 a.m. CDT on Thursday, January 27. Interested parties can listen to the call by dialing toll-free 1-866-298-7926 (United States and Canada only) and asking for the Simmons First National Corp. conference call, conference ID 7373369. In addition, the call will be available live or in recorded version on the company’s website at simmonsbank.com under “Investor Relations.” The recorded version will be available for at least 60 days following the date of the call.
Simmons First National CorporationSimmons First National...
Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference
Written by Customer Service on . Posted in Public Companies.
DEERFIELD, Ill., Dec. 20, 2021 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate in the 2022 H.C. Wainwright Virtual BioConnect Conference taking place January 10-13, 2022.
A recording of the Company’s presentation will be available Monday, January 10, 2022 at 7am ET. To access please visit the investor relations page of the Company’s website at surgalign.com/investors/. Replays of the webcasts will be archived on the website for approximately 90 days.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital surgery and is building out its digital surgery platform to drive...
Alton Frailey Appointed to Southside Bancshares, Inc. Board of Directors
Written by Customer Service on . Posted in Public Companies.
TYLER, Texas, Dec. 20, 2021 (GLOBE NEWSWIRE) — Southside Bancshares, Inc. (the “Company”) (NASDAQ:SBSI), the holding company of Southside Bank (the “Bank”), announced the appointment of Alton L. Frailey to the Company’s board of directors on November 24, 2021, effective January 1, 2022, increasing the size of the Company’s board to 17 members. Mr. Frailey was also appointed to the Bank’s board of directors, effective January 1, 2022, increasing the size of the Bank board to 18 members.
Residing in the greater Houston area, Mr. Frailey is President of Alton L. Frailey & Associates, LLC, specializing in leadership development, community engagement, school board team building and executive coaching. Mr. Frailey has been involved in education for 35 years, serving most recently as the past superintendent for Katy Independent School...
BioDelivery Sciences Prevails in BELBUCA® ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032
Written by Customer Service on . Posted in Public Companies.
RALEIGH, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that the U.S. District Court of Delaware has issued an opinion in favor of BDSI in the company’s patent litigation against Alvogen Group, Inc. and its affiliates, who filed an Abbreviated New Drug Application (ANDA) for BDSI’s BELBUCA® product on May 23, 2018. The opinion by the trial judge upholds the validity of claims in BDSI’s patents 8,147,866 (the ‘866 patent), which expires in 2027, and 9,901,539 (the ‘539 patent), which expires in 2032. Alvogen conceded infringement of these claims. Accordingly, BDSI expects market exclusivity of BELBUCA against Alvogen until 2032.
“We are pleased with...
Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2022
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
On track for record revenue and solid profitability in fiscal 2022
BOISE, Idaho, Dec. 20, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2022, which ended Dec. 2, 2021.
Fiscal Q1 2022 highlightsRevenue of $7.69 billion versus $8.27 billion for the prior quarter and $5.77 billion for the same period last year
GAAP net income of $2.31 billion, or $2.04 per diluted share
Non-GAAP net income of $2.47 billion, or $2.16 per diluted share
Operating cash flow of $3.94 billion versus $3.88 billion for the prior quarter and $1.97 billion for the same period last year“Micron delivered solid fiscal first quarter results led by strong product portfolio momentum,” said Micron Technology President and CEO Sanjay Mehrotra. “We are now shipping our industry-leading DRAM and...
Calavo Growers, Inc. Announces Fourth Quarter and Fiscal 2021 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
SANTA PAULA, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of value-added fresh food, today reported its financial results for the fourth quarter and fiscal year ended October 31, 2021.
Fourth Quarter Financial OverviewTotal revenue of $273.4 million, a 17% increase from the year-ago quarter.
Fresh segment revenue increased 26% year-over-year to $149.8 million, and Renaissance Food Group (RFG) and Foods segments revenues increased 7% and 6% year-over-year, respectively.
Gross profit of $9.1 million, or 3.3% of revenue, compared to $21.2 million, or 9.0% of revenue, for the year-ago quarter.
Net loss of $(13.0) million, or $(0.73) per share, compared to net income of $6.2 million, or $0.35 per diluted share, for the same period last year.
Adjusted...
Immix Biopharma, Inc. Announces Closing of Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
LOS ANGELES, CA, Dec. 20, 2021 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the “Company”), a biopharmaceutical company pioneering Tissue Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, today announced the closing of its initial public offering of 4,200,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $21,000,000, before deducting underwriting discounts, commissions and offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 630,000 shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments.
The shares began trading on the Nasdaq Capital Market on December 16, 2021 under the ticker symbol “IMMX.”
ThinkEquity...
McLaren Technology Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants
Written by Customer Service on . Posted in Public Companies.
Irvine, California, Dec. 20, 2021 (GLOBE NEWSWIRE) — McLaren Technology Acquisition Corp. (the “Company”) announced today that, commencing December 23, 2021, holders of the 20,125,000 units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A common stock and warrants included in the units. Class A common stock and warrants that are separated will trade on the Nasdaq Stock Market LLC under the symbols “MLAI” and “MLAIW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “MLAIU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to...